![Jaume Pons](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jaume Pons
Fondateur chez
Alx Oncology Ltd.
Fortune : 939 966 $ au 31/05/2026
Profil
Jaume Pons is the founder of ALX Oncology Ltd., founded in 2015, serving as President, Chief Executive Officer & Director.
Dr. Pons was the founder of ALX Oncology Holdings, Inc., founded in 2015, serving as President & Chief Scientific Officer from 2024 to 2025.
Dr. Pons is also the founder of ALX Oncology, Inc.,Tallac Therapeutics, Inc...
Dr. Pons currently serves as Director at Alexo Therapeutics International and Sirpant Therapeutics.
Dr. Pons is Scientific Advisor at LSV Capital Management LLC.
Dr. Pons is Venture Partner at venBio Partners LLC since 2015.
Formerly, Dr. Pons was Chief Scientific Officer at Pfizer Inc. from 2007 to 2015.
Dr. Pons was Chief Scientific Officer at Rinat Neuroscience Corp.
from 2007 to 2015.
Dr. Pons completed graduate studies at the University of California, Berkeley.
Dr. Pons completed undergraduate, graduate, and doctorate degrees at the Autonomous University of Barcelona.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 494 719 ( 0,37 % ) | 939 966 $ | 31/05/2026 |
Postes actifs de Jaume Pons
| Sociétés | Poste | Début |
|---|---|---|
venBio Partners LLC
 venBio Partners LLC Investment ManagersFinance venBio invests in companies located in the United States. The firm focuses on companies operating in the fields of life sciences sectors. It participates in early to late stage transactions. The firm acts as a lead investor. | Private Equity Investor | 04/01/2015 |
Alx Oncology Ltd.
 Alx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Operates as biotechnology company developing immuno-oncology therapies for cancer | Fondateur | 01/04/2015 |
Alexo Therapeutics International
 Alexo Therapeutics International Pharmaceuticals: MajorHealth Technology Alexo Therapeutics International develops immune-oncology therapies for cancer. The company is headquartered in South San Francisco, CA. | Directeur/Membre du Conseil | - |
Tallac Therapeutics, Inc.
 Tallac Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of immunomodulation polynucleotides | Fondateur | - |
Sirpant Therapeutics | Directeur/Membre du Conseil | - |
LSV CAPITAL MANAGEMENT LLC
 LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, biotech, and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Consultant / Advisor | - |
Anciens postes connus de Jaume Pons
| Sociétés | Poste | Fin |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Directeur Général | 06/09/2023 |
Rinat Neuroscience Corp.
 Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Directeur Technique/Scientifique/R&D | 01/02/2015 |
ALX Oncology, Inc.
 ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company which develops therapies for cancers | Directeur Général | - |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Formation de Jaume Pons
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rinat Neuroscience Corp.
Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Health Technology |
venBio Partners LLC
venBio Partners LLC Investment ManagersFinance venBio invests in companies located in the United States. The firm focuses on companies operating in the fields of life sciences sectors. It participates in early to late stage transactions. The firm acts as a lead investor. | Finance |
Autonomous University of Barcelona
 Autonomous University of Barcelona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LSV CAPITAL MANAGEMENT LLC
LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm targets companies operating in the fields of healthcare, biotech, and medtech sectors. It provides financing for seed, early, and later stage capital requirements. | Finance |
Alx Oncology Ltd.
Alx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Operates as biotechnology company developing immuno-oncology therapies for cancer | Health Technology |
ALX Oncology, Inc.
ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company which develops therapies for cancers | Health Technology |
Tallac Therapeutics, Inc.
Tallac Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of immunomodulation polynucleotides | Health Technology |
ALX Oncology Holdings, Inc.
 ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
Alexo Therapeutics International
Alexo Therapeutics International Pharmaceuticals: MajorHealth Technology Alexo Therapeutics International develops immune-oncology therapies for cancer. The company is headquartered in South San Francisco, CA. | Health Technology |
Sirpant Therapeutics |
